Adverse reactions of the digestive system caused by glucagon-like peptide-1 receptor agonists
Glucagon-like peptide-1 receptor agonists(GLP-1RAs)have been widely used in diabetes and obese people in recent years,and they have also caused a series of adverse reactions,the most important of which is digestive system-related adverse reactions.The adverse reactions of the digestive system associated with GLP-1RAs involve the gastrointestinal,pancreatic,and biliary tracts;among them,nausea,vomiting,constipation,and diarrhea are the most common adverse reactions,which are the main reasons for drug withdrawal.The incidence of pancreatic and biliary system diseases is low,but there is no research evidence to exclude their association with GLP-1RAs.Tirzepatide appears on the market relatively late,and its safety still lacks sufficient real-world data.Medical staff should adopt active dietary guidance strategies for patients and strengthen medication education to help patients actively prevent and scientifically respond to adverse reactions in the digestive system.
万方数据
维普
